1. Home
  2. BLFS vs ARI Comparison

BLFS vs ARI Comparison

Compare BLFS & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • ARI
  • Stock Information
  • Founded
  • BLFS 1987
  • ARI 2009
  • Country
  • BLFS United States
  • ARI United States
  • Employees
  • BLFS N/A
  • ARI N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • ARI Real Estate Investment Trusts
  • Sector
  • BLFS Health Care
  • ARI Real Estate
  • Exchange
  • BLFS Nasdaq
  • ARI Nasdaq
  • Market Cap
  • BLFS 1.2B
  • ARI 1.1B
  • IPO Year
  • BLFS 1989
  • ARI 2009
  • Fundamental
  • Price
  • BLFS $23.29
  • ARI $9.59
  • Analyst Decision
  • BLFS Strong Buy
  • ARI Hold
  • Analyst Count
  • BLFS 7
  • ARI 5
  • Target Price
  • BLFS $30.57
  • ARI $9.50
  • AVG Volume (30 Days)
  • BLFS 573.8K
  • ARI 1.3M
  • Earning Date
  • BLFS 05-08-2025
  • ARI 04-24-2025
  • Dividend Yield
  • BLFS N/A
  • ARI 10.44%
  • EPS Growth
  • BLFS N/A
  • ARI N/A
  • EPS
  • BLFS N/A
  • ARI N/A
  • Revenue
  • BLFS $87,762,000.00
  • ARI $276,844,000.00
  • Revenue This Year
  • BLFS $20.32
  • ARI $36.32
  • Revenue Next Year
  • BLFS $19.98
  • ARI $14.83
  • P/E Ratio
  • BLFS N/A
  • ARI N/A
  • Revenue Growth
  • BLFS N/A
  • ARI 104.64
  • 52 Week Low
  • BLFS $17.15
  • ARI $7.70
  • 52 Week High
  • BLFS $29.55
  • ARI $11.20
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 49.30
  • ARI 60.04
  • Support Level
  • BLFS $21.13
  • ARI $9.30
  • Resistance Level
  • BLFS $25.60
  • ARI $9.54
  • Average True Range (ATR)
  • BLFS 1.58
  • ARI 0.20
  • MACD
  • BLFS -0.07
  • ARI 0.09
  • Stochastic Oscillator
  • BLFS 48.32
  • ARI 97.77

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: